Search Results for "April 2013 Update On Transvaginal Mesh Lawsuits"

15:38 EDT 20th October 2016 | BioPortfolio

Matching Channels

Proliferation inducing ligand APRIL

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...


The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and ...


Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

Kinases Raf Inhibitors

The Ras-Raf-MEK-ERK (ERK) pathway is a logical therapeutic target because it represents a common downstream pathway for several key growth factor tyrosine kinase receptors which are often mutated or...

Matching News

Johnson & Johnson now being sued by 3 states over vaginal mesh implants

Kentucky has filed a lawsuit against Johnson & Johnson’s medical device unit, Ethicon, alleging it concealed and purposely misrepresented the risks involved in its surgical transvaginal mesh pr...

Study finds mixed results for use of mesh for hernia repair

Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, alt...

UPDATE 1-Judge rules against some 1,300 lawsuits over Bayer's Mirena IUD

A New York federal judge has ruled in favor of Bayer AG against nearly 1,300 lawsuits filed by women who say they suffered internal injuries from the company's Mirena intra-uterine contraceptive d...

Judge Says He's Had Enough Of Weeding Through Baseless Lawsuits, Threatens Sanctions

A judge speaks frankly about what he plans to do if lawyers keep pressing questionable vaginal-mesh cases.

Two states sue Johnson & Johnson over vaginal mesh device problems

The attorney generals of California and Washington filed lawsuits alleging the company failed to disclose risks to consumers. 

UPDATE 2-California sues Johnson & Johnson over marketing for pelvic mesh

NEW YORK, May 24 (Reuters) - California has accused Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complications associated with its pelvic mesh devices....

UPDATE 1-California AG sues Johnson & Johnson over marketing for pelvic mesh

NEW YORK, May 24 (Reuters) - California's attorney general filed a lawsuit on Tuesday accusing Johnson & Johnson of failing to warn doctors and patients about the severity and frequency of complicatio...

Washington, California Sue J&J In Latest Legal Action Against Vaginal Mesh Implants

The plastic mesh is used to treat pelvic organ prolapse. In response to thousands of injuries from the mesh, the Food and Drug Administration early this year re-labeled the products high risk instead ...

Matching PubMed Articles

Graft and Mesh Use in Transvaginal Prolapse Repair: A Systematic Review.

To update clinical practice guidelines on graft and mesh use in transvaginal pelvic organ prolapse repair based on systematic review.

Analysis of Surgical Outcomes and Determinants of Litigation Among Women With Transvaginal Mesh Complications.

To identify litigation predictors among women with complications of transvaginal mesh.

Surgeon Experience and Complications of Transvaginal Prolapse Mesh.

To measure the proportion of women with transvaginal prolapse mesh complications and their association with surgeon volume.

Age-stratified analysis of long-term outcomes of transvaginal mesh repair for treatment of pelvic organ prolapse.

To investigate long-term outcomes after transvaginal mesh repair among patients with pelvic organ prolapse in different age groups.

Cost analysis of surgical treatment for pelvic organ prolapse by laparoscopic sacrocolpopexy or transvaginal mesh.

The objective of this study is to compare direct costs of repairing pelvic organ prolapse by laparoscopic sacrocolpopexy (LS) against vaginal mesh (VM). Our hypothesis is the correction of pelvic orga...

Search Whole site using Google

Quick Search
Advertisement Advertisement